Telehealth platform Wisp is launching a new healthy aging category, believing that women’s longevity care is a gap and the next major opportunity.
for years Wisp was best known for meeting women, where many traditional medical services are often cut short: online, smart and without the hassle that often turns basic care into an ordeal.
Now the New York company is taking this model in a more ambitious place. Wisp, which bills itself as the largest women’s phone provider in the U.S., has launched a new longevity and healthy aging category, a move that pushes it beyond reproductive and sexual health and into longevity, one of the most crowded, confusing and lucrative corners of modern medicine (1).
At first glance, the new proposal may sound familiar to anyone who has spent time on the health internet. Early treatments include NAD+, glutathione, and low-dose naltrexone (LDN), names thrown around in biohacking circles and high-end wellness clinics.
Wisp tries to tell a different story. Rather than packaging longevity as a playground for egos chasing the next career achievement, it positions these treatments as part of clinical care for women navigating the slower, messier realities of aging. Fatigue that does not go away at all. Brain fog, which is sometimes less noticeable. Hormonal changes that disrupt sleep, mood, and energy. A quiet desperation that says “wait and see”.
It’s long-winded, but translated to real life. For all its great promise, longevity still has access issues, which is why what Wisp does is so important.
Too many categories are shrouded in jargon, expensive protocols, and language that makes everyday patients feel like they need a degree in biochemistry just to understand the surface. The Wisp movement offers a simpler proposition: take some of the science people are already hearing about, strip away the cultural gloss, and make it into a model of care that looks less like a fad and more like a health service.
In practical terms, the company says the treatments are designed to support areas such as energy production, cell repair and immune function. It’s better understood less as “anti-aging magic” and more as maintenance. Think of it as trying to keep the body’s internal systems running smoothly for longer periods of time.
Patients with access to the new category will receive asynchronous consultations, clinical supervision and ongoing treatment adjustments through Wisp’s digital platform. This may sound procedural, but it is essential in the business model. It’s not just about selling sprays or injections online; it’s about turning longevity into repeat relationships, not one-time purchases.
Wisp’s expansion points to a broader shift in how longevity is commercialized. The first wave of this sector was often built around aspiration: high-end supplements, advanced testing, concierge clinics, and a biohacking culture that catered to men, the wealthy, and the task-oriented. The next phase may be less glamorous but more scalable – integrating healthy aging into mainstream digital care. And women may be one of the most obvious places to start.
According to a Wisp survey of nearly 2,000 women in the U.S., 75% said they already prioritize long-term health in their daily choices. However, nearly half said they don’t know which interventions actually work for women’s bodies (2). Even more telling, 92% believe mobile health is important to healthy aging, but only 11% think current digital tools give them a sense of control over their long-term health.
This space—between desire and trust, between access and real trust—is where Wisp plants its flag.
According to Wisp CEO Monika Chepak, women are being left behind as the telemedicine market for treatments like NAD+ and glutathione becomes more expensive and fragmented.
“Women are navigating complex hormonal transitions and immune issues that don’t fit into the standard biohacking framework. We translate complex science into clear, clinician-driven plans that support women long before things escalate,” she said.
It is difficult to ignore the longevity of women
If longevity is often marketed as universal, the reality is that much of the industry is not built that way.
Women experience aging through a variety of biological and social pressures, particularly around perimenopause and menopause, where symptoms like chronic fatigue, cognitive impairment, and immune-related issues may be dismissed, normalized, or treated in isolation rather than as part of a larger conversation.
That’s why Wisp’s move feels timely. This is a reflection of the growing recognition that the future of longevity will be won not only by whoever promises the longest life, but by whoever makes long, healthier lives feel believable and viable for ordinary people.
“We help women take control of their lives, not just their lives,” said Dr. Shannon Chatham, Wisp’s medical director. “It’s not about chasing trends, it’s about providing evidence-based, sustainable care that meets the real needs of women as they age.”
The bigger question is about longevity
There is, of course, a caveat here. Longevity remains an area where marketing often precedes evidence, and any company entering the space must prove it can balance consumer demand with clinical rigor.
However, Wisp’s opening captures something important about where the sector is headed. Longevity is no longer just a luxury identity project for people with cash, trackers and cool dips. Increasingly, it is becoming a delivery model that combines prevention, digital access and long-term patient engagement. And if that future is to be meaningful, it can’t just speak to the same audience.
Wisp’s premise is that women need care that really suits their age. In the long run, this is more sustainable innovation and smarter business.
(1) https://www.businesswire.com/news/home/20260310550128/en/Wisp-Debuts-Women-Centric-Longevity-Suite-Via-New-Healthy-Aging-Vertical
(2) https://hellowisp.com/blog/closing-longevity-gap-for-women
